Original Research Paper

Antinociceptive effects, acute toxicity and chemical composition of Vitex

agnus-castus essential oil
Emad Khalilzadeh1*, Gholamreza Vafaei Saiah1, Hamideh Hasannejad1, Adel Ghaderi1,
Shahla Ghaderi1, Gholamreza Hamidian2, Razzagh Mahmoudi3, Davoud Eshgi1, Mahsa
Zangisheh1
1

Division of Physiology, Department of Basic Science, Faculty of Veterinary Medicine, University of Tabriz,
Tabriz, I.R.Iran.
2
Division of Histology, Department of Basic Science, Faculty of Veterinary Medicine, University of Tabriz,
Tabriz, I.R.Iran.
3
Department of Food Hygiene and Aquatics, Faculty of Veterinary Medicine, University of Tabriz, Tabriz,
I.R.Iran.
Article history:
Received: Sep 14, 2014
Received in revised form:
Sep 16, 2014
Accepted: Oct 21, 2014
Vol. 5, No. 3, May-Jun 2015,
218-230.
* Corresponding Author:
Tel: +984136378743
Fax: +984136378744
[email protected]
[email protected]
Keywords:
Vitex agnus-castus
Antinociception
Acute toxicity
Chemical composition
Rat

Abstract
Objective: Vitex agnus-castus (VAC) and its essential oil have
been traditionally used to treat many conditions and symptoms
such as premenstrual problems, mastalgia, inflammation, sexual
dysfunction, and pain. In this study, the effects of essential oil
extracted from Vitex agnus-castus (EOVAC) leaves were
investigated in three behavioral models of nociception in adult
male Wistar rats.
Materials and methods: Chemical composition of EOVAC was
analyzed using gas chromatography mass spectrometry (GCMS) and also its possible toxicity was determined in mice.
Analgesic effect of EOVAC was determined using tail immersion
test, formalin test, and acetic acid-induced visceral pain in rats.
Results: EOVAC (s.c.) and morphine (i.p.) significantly (p<0.05)
reduced pain responses in both formalin and tail immersion
tests. In the study of evolved mechanisms, pretreatment with
naloxone or atropine significantly (p <0.05) reversed the essential
oil-induced analgesia in both formalin and tail immersion tests.
Moreover, EOVAC and Piroxicam produced significant (p<0.05)
inhibition in the acetic acid-induced writhing response. EOVAC
did not show any mortality even at high dose (5 g/kg, p.o.) of
administration in toxicity test. Moreover, according to GC-MS
results, major components of the EOVAC were -pinene
(14.83%), limonene (10.29%), -caryophyllene (6.9%), sabinene
(5.27%), and -farnesene (5.9%).
Conclusions: These results suggest that endogenous opioidergic
system as well as muscarinergic receptors of cholinergic system
may be involve in the antinociceptive activity of Vitex agnuscastus essential oil in these models of pain in rats.

Please cite this paper as: Khalilzadeh E, Vafaei Saiah G, Hasannejad H, Ghaderi A, Ghaderi Sh, Hamidian G,
Mahmoudi R, Eshgi D, Zangisheh M. Antinociceptive effects, acute toxicity, and chemical composition of Vitex
agnus-castus essential oil. Avicenna J Phytomed, 2015; 5 (3): 218-230.

AJP, Vol. 5, No. 3, May-Jun 2015

218

Effect of Vitex agnus-castus essential oil on pain

Introduction
Vitex agnus-castus (VAC) is a small
deciduous shrub commonly known as
monk pepper or chaste tree belonging to
the Lamiaceae family of plants that is
widely distributed in the Middle East and
Mediterranean region (Stojkovic' et al.,
2011). VAC is traditionally used as a
treatment for menstrual problems,
inflammation, sexual dysfunction, and pain
(Upton, 2001). In the Iranian folk
medicine, VAC is used as anticonvulsant,
antiepileptic,
carminative,
energizer,
sedative, anticonvulsant, constipation, and
reduction of libido (Nasri and Ebrahimi,
2006; Saberi et al., 2008; Ramazani et al.,
2010; Safa et al., 2012).
Different kind of extracts from VAC
have
been
reported
to
produce
antinociceptive and anti-inflammatory
effects (Ramazani et al., 2010), enhance
female fertility (Dugoua et al., 2008), and
reduce moderate to severe symptom of
premenstrual syndrome (PMS) such as
mastalgia, headache, fatigue, anxiety, and
depression (Atmaca et al., 2003;
Prilepskaya et al., 2006). Moreover,
essential oil of VAC has shown antimicrobial and anti-fungal activities
(Choudhary et al., 2009; Ghannadi et al.,
2012).
Essential oil is a volatile aromatic
compound from plants that have been used
medicinally throughout history (Christaki
et al., 2012). EOVAC contains some
important
monoterpenes
and
sesquiterpenes such as -pinene, bisabolol, 1,8-cineol, -caryophyllene, and
limonene (Stojkovic' et al., 2011; Ghannadi
et al., 2012 ). Previous studies have
indicated that some of these terpenes have
anti-inflammatory and antinociceptive
effects in different models of pain and
inflammation (Guimares et al., 2013).
There are some other monoterpenes in the
EOVAC such as -phellandrene and
Linalool. It has been shown that both phellandrene and linalool could produce
analgesia via cholinergic and opioidergic
systems in different models of pain in the

rodents (Peana et al., 2003; Lima et al.,

2012).
Beneficial effect of VAC extracts in the
treatment of PMS symptoms has caused an
increasing interest for determination of its
possible mechanisms of action in PMS
symptoms. Moreover, recently, Webster et
al., (2011) reported that therapeutic effects
of different fraction of VAC extract are
mediated through the activation of and
but not opioid receptors.
Despite the demonstration of the
efficacy of VAC extracts in the treatment
of PMS symptoms and reduction of pain
perception, nothing has been published
about the effects of EOVAC in pain
modulation. Therefore, the present study
was
aimed
to
investigate
the
antinociceptive activity of EOVAC on the
chemical, thermal, and inflammatory
models of pain. Moreover, we used
naloxone (nonselective opioid receptors
antagonist) and atropine (nonselective
muscarinic receptors antagonist) to
determine its possible opioidergic or
cholinergic mechanisms of action in these
models of pain.
The content and composition of
extracted essential oils from one plant
species vary in different seasons, soil
component, and weather conditions
(D'Antuono et al., 2000). Because of these
reasons, our extracted essential oil was
analyzed using GC-MS to determine its
active ingredients.

Materials and Methods

Animals
Adult male Wistar rats, weighing 250280 g and adult male Swiss albino mice,
weighing 20-25 g of were used in this
study. They were randomly housed in
polyethylene cages with ad libitum access
to food and water in a room with
controlled temperature (221 C) and
under a 12 h lightdark cycle (lights on
from 07:00 h). Seven, Six, and five rats
were used in each group of tail immersion,
formalin, and writhing tests, respectively.
All experiments were performed between

AJP, Vol. 5, No. 3, May-Jun 2015

219

Khalilzadeh et al.

11:00 h and 15:00 h. All research and

animal care procedures were approved by
the Veterinary Ethics Committee of the
Faculty
of
Veterinary
Medicine,
(University of Tabriz), Iran and were
performed in accordance with the current
guidelines for the care of laboratory
animals and the ethical guidelines for
investigations of experimental pain in
conscious animals (Zimmermann, 1983).
Drugs and chemicals
Morphine sulfate was purchased from
Tolid Darou Co. (Tehran, Iran). Atropine
and naloxone hydrochloride, piroxicam
and Tween 80 were purchased from Sigma
Chemical Co. (St. Louis, MO, USA) and
formalin solution 37% was purchased from
Merck Chemicals (Darmstadt, Germany).
Acetic acid solution 99.5% was purchased
from Dr. Mojallali Chemicals Co.
(Teheran, Iran). All drugs and chemicals
were dissolved in physiological saline. An
emulsion of essential oil was prepared
using Tween 80 and saline (2%, v/v) as
solvent.
Plant material and essential oil
extraction
The leaves of Vitex agnus-castus was
collected during August - September in
2012 from vicinity of Maragheh county in
the East Azerbaijan, Iran and were
subsequently authenticated by Dr Fatemeh
khoshbakht Koolagh, a botanist at the
Herbarium of Faculty of agriculture,
University of Tabriz, Tabriz, Iran. A
voucher specimen (16697) was deposited
at the Herbarium of Faculty of agriculture.
The leaves were dried in room temperature
avoiding from direct sunlight and then
ground into a fine powder.
The essential oil of Vitex agnus-castus
leaves were extracted from powdered plant
by hydrodistillation in a Clevenger type
apparatus for 4 h and produced 0.7% (v/w)
yield. Obtained essential oil was dried over
anhydrous sodium sulfate until the last
traces of water were removed, and then

stored in dark glass bottles at 4 C

(Mahmoudi et al., 2014).
Nociceptive tests
Formalin Pain
For reduction of possible effect of stress
during the test, on three successive days
prior to the formalin test, animals were
placed for 30 min inside a Plexiglas
observation chamber (303025 cm3)
equipped with a mirror angled at 45
below the chamber (Abbott and Bonder,
1997; Khalilzadeh et al., 2010). In the test
day after a 30-min adaptation period,
formaldehyde solution (2.5% in saline, 50
l/paw) was injected subcutaneously into
the ventral surface of the right hind paw
using a 30-gauge injection needle
(Khalilzadeh et al., 2010).
Following formalin injection, the rat
was immediately put back into the opaque
observation chamber. The time spent in
licking and biting of the injected paw
determined as a nociceptive behavior and
was recorded in uninterrupted 5-min
blocks over a period of 45 min. The first 5
min measured as the first phase (phasic
pain, neurogenic phase) while the period
between 15 - 45 min was considered as the
second phase (inflammatory pain)
(Khalilzadeh et al., 2010).
Tail Immersion Test
The tail of rats was immersed (5cm) in
a water bath at noxious temperature of
550.5 C until the tail was withdrawn or
the whole body was recoiled. The cut-off
time was fixed at 15 s to prevent any tissue
damage to the tail (Le bars et al., 2001).
Reaction latencies at 0, 15, 30, 45, 60, and
90 min after chemicals administration
were used as a parameter reflecting of the
pain experienced.
Treatment groups in formalin and tail
immersion tests
Group 1: This group received s.c.
injection of vehicle (Tween 80, 2% v/v in
saline, 200 l) before intraplantar injection
of formalin or tail immersion test.

AJP, Vol. 5, No. 3, May-Jun 2015

220

Effect of Vitex agnus-castus essential oil on pain

Groups 2, 3, 4, and 5: In these groups,

s.c. injection of EOVAC at doses of 25,
37.5, 50, and 62.5 mg/kg, respectively,
were performed before intraplantar
injection of formalin or tail immersion test.
Groups 6, 7, and 8: In these groups, i.p.
injection of saline (200 l/rat), morphine
(10 mg/kg), naloxone (1 mg/kg),
andatropine (1 mg/kg), respectively were
performed before intraplantar injection of
formalin or tail immersion test.
Groups 9 and 10: These groups
received i.p. injection of naloxone (1
mg/kg) and atropine at a dose of 1 mg/kg,
respectively with s.c. injection of EOVAC
(50 mg/kg) before intraplantar injection of
formalin or tail immersion test.
The i.p. injections of naloxone and
atropine were performed 40 min before
intraplantar injection of formalin and 10
min before starting tail immersion test.
The s.c. injections of EOVAC and i.p.
injection of morphine were performed 30
min before intraplantar injection of
formalin and 0 min (immediately after
injection) before tail immersion test.
Acetic acid induced writhing response in
rat
The test was carried out using the
technique previously described by
Tamaddonfard et al., (2008). For
adaptation of animals to test environment,
they were placed 30 min inside a Plexiglas
opaque chamber (403020 cm3) that
equipped with a mirror angled at 45
below the chamber. Using a 27-gauge
injection needle, Tween 80 (2%, s.c.,
200l) as control, EOVAC (25 and 50
mg/kg) and piroxicam (50 mg/kg)
subcutaneously injected 30 min before
intraperitoneal injection of acetic acid (2%
v/v in saline, 4 ml/kg). Immediately after
the injection of acetic acid, frequency of
writhing response was recorded in 5-min
periods during the test which lasted 40
min. Moreover, latency time to the
beginning of the first abdominal
contraction (first writhe) was recorded. A
writhe was defined as a wave of the

contraction of the abdominal musculature

followed by extension of the hind limbs
(Ness, 1999; Le Bars et al., 2001).
Acute toxicity in mice
For determination of chronic toxicity of
essential oil, it was administrated at doses
of 1000, 2000, 3000, and 5000 mg/kg/200
l (p.o.) in four groups of mice (n=6 in
each group). One group received an equal
volume of Tween 80, 2% in normal saline
as a solvent of essential oil. Animals'
mortality was observed for 2 days. Food
and water were provided ad libitum.
Essential oil GC-MS analyze
The essential oil was analyzed by gas
chromatographymass spectrometry (GCMS). The chromatograph instrument
(Agilent 6890, UK) was equipped with an
HP-5MS capillary column (30 0.25 mm
ID 0.25 mm film thickness) and the data
were taken under the following conditions:
initial temperature 50C, temperature ramp
5C/min, 240C/min to 300C (holding for
3 min), and injector temperature at 290C.
The carrier gas was helium and the split
ratio was 0.8 mL-1/min. For confirmation
of analysis results, EOVAC was also
analyzed by gas chromatographymass
spectrometry
(Agilent
6890
gas
chromatograph equipped with an Agilent
5973 mass-selective detector; Agilent UK)
with similar capillary column and
analytical conditions as above. The MS
was run in electron-ionization mode with
ionization energy of 70 eV (Mahmoudi et
al., 2014).
Statistical analysis
Data were analyzed using one-way
analysis of variance (ANOVA) followed
by Tukeys HSD post hoc test for both
formalin and writhing tests data and twoway analysis of variance (ANOVA) with
repeated measures followed by Tukey's
post hoc test was applied for determination
of significance value in the tail immersion
test using IBM SPSS software version
19 (IBM company, USA). Statistical
differences between two control groups of
formalin test were analyzed using student

AJP, Vol. 5, No. 3, May-Jun 2015

221

Khalilzadeh et al.

t-test. In figures, all values were expressed

as mean SEM. A value of p<0.05 was
considered as statistically significant.

Results
Tail immersion test
There were not significant differences
between normal saline (200l, i.p) and
vehicle (Tween 2% v/v in saline, 200l,
s.c.) treated groups in the tail immersion
test (Figure 1).

Figure 1. The effects of normal saline (200 l, i.p.)

and Tween 80 (2%, 200l, s.c.) administration on
withdrawal latency in rats. Values are expressed as
the meanSEM (n=7/group).

Therefore, the obtained data from

experimental groups were compared with
vehicle treated group. Subcutaneous

injection of 25 mg/kg of EOVAC failed to

prolong withdrawal latency during the
observation period. The effect of EOVAC
(37.5 mg/kg, s.c.) on reaction latency was
statistically significant (3.99 0.49,
p<0.05) at 45 min compared with the same
time point of control value. The effect of
EOVAC (50 mg/kg, s.c.) on reaction
latency was statistically significant (4.60
0.62, 4.42 0.53, 4.51 0.70, and 3.88
0.47, p<0.05 and p<0.001) at 15, 30, 45,
and 90 min, respectively compared with
the same time point of control value. The
effect of EOVAC (62.5 mg/kg, s.c.) on
reaction
latency
was
statistically
significant (3.87 0.51 and 3.81 0.43,
p<0.05 and p<0.001) at 30 and 45 min,
respectively compared with the same time
point of control value (Figure 2).
Morphine analgesic activity was started
30 min after i.p. injection which lasted
until the end of observation period
(p<0.001) (Figure 2).
Naloxone (1 mg/kg) and atropine (1
mg/kg) alone showed no significant effect
but pre-treatment of animals with naloxone
or atropine completely prevented (p<0.05)
the EOVAC (50 mg/kg) analgesic activity
during the observation period (Figure 3).

Figure 2. The effects of essential oil of Vitex agnus-castus and morphine on withdrawal latency in rats. *
p<0.05 and ** p<0.001 as compared with the control group (n=7/group). (Two-way analysis of variance
(ANOVA) with repeated measures followed by Tukeys post hoc test), EOVAC: Essential oil of Vitex
agnus-castus, Morph: Morphine, 0 min: Immediately after injection.

AJP, Vol. 5, No. 3, May-Jun 2015

222

Effect of Vitex agnus-castus essential oil on pain

Figure 3. The effects of pretreatment with naloxone and atropine on Vitex agnus-castus essential oil induced
antinociception in tail immersion test. * p<0.05 as compared with the control group. p<0.05 as compared with
the EOVAC 50 mg/kg treated group (n=7/group). (Two-way analysis of variance (ANOVA) with repeated
measures followed by Tukeys post hoc test). EOVAC: Essential oil of Vitex agnus-castus, Morph: Morphine,
Nalox: Naloxone, Atrop: Atropine.

Formalin test
The intraplantar injection of the
formalin 2.5% solution after vehicle
(Tween 80, 2% v/v in saline, 200l, s.c.)
or saline (200l, i.p.) produced nociceptive
behavior in both the first (7110.6 s and
81.55.94 s, respectively) and second
phases (154.5 22.7 s and 169.6610.50 s,
respectively) without any significant
differences (Figure 4).

Figure 4. Formalin-induced nociceptive behavior

(licking and biting) in normal saline (200 l, i.p.)
andTween 80 (2%, 200l, s.c.) treated groups.
Values are expressed as the meanSEM
(n=6/group).

Therefore, the obtained data from

experimental groups were compared with
vehicle-treated group. EOVAC at doses of

25 and 37.5 mg/kg produced no significant

effects in both first and second phase of
formalin pain (Figure 5).
The s.c. injection of EOVAC at doses
of 50 and 62.5 mg/kg induced a significant
(p<0.05) antinociceptive effect compared
to the control group in the both first
(35.834.81 s and 18.36.4 s, respectively)
and second phases (89.35.8 s and
66.511.5 s, respectively) of the formalin
test (Figure 5).
Morphine (10 mg/kg, i.p.) significantly
inhibited nociception in the both first
(7.52.1 s, p<0.05) and second phases
(35.513.4 s, p<0.05) of formalin test.
Opioid receptors antagonist naloxone (1
mg/kg) and non-selective muscarinic
receptors antagonist atropine (1 mg/kg)
alone had not any significant effect on
both phases of formalin test (Figure 6).
Pre-treatment of animals with naloxone
completely prevented the EOVAC (50
mg/kg) analgesic effect in the first (532.6
s, p<0.05) and second phase (151.615.4 s,
p<0.05) of formalin test but atropine
inhibited EOVAC analgesic effect only in
the second phase (155.337.8 s, p<0.05) of
formalin test (Figure 6).

AJP, Vol. 5, No. 3, May-Jun 2015

223

Khalilzadeh et al.

Figure 5. The effects of essential oil of Vitex agnus-castus and morphine on formalin pain response in rats. *
p<0.05 as compared with control group (n=6/group). (One way ANOVA followed by Tukeys HSD post hoc
test). EOVAC: Essential oil of Vitex agnus-castus, Morph: Morphine.

Figure 6. The effects of pretreatment with naloxone and atropine on essential oil of Vitex agnus-castus
induced antinociception in formalin pain response. * p<0.05 as compared with control group. p<0.05 as
compared with EOVAC 50 mg/kg treated group (n=6/group). (One way ANOVA followed by Tukeys
HSD post hoc test). EOVAC: Essential oil of Vitex agnus-castus, Morph: Morphine, Nalox: Naloxone,
Atrop: Atropine.

Acetic acid-induced writhing response

in rat
The results presented in Figures 7A and
7B shows that EOVAC at doses of 50
mg/kg but not 25 mg/kg significantly
(22.46.6 n, p<0.01) reduced number of
abdominal writhes in comparison with
control group (44.44 n, p<0.01) in the
acetic acid induced visceral pain (Figure
7b). Administration of non-selective
cyclooxygenase inhibitor (piroxicam, 5

mg/kg) significantly (14.41.9 n, p<0.01)

reduced number of abdominal writhes and
also significantly (15.882.47 min,
p<0.05) increased latency time to the
beginning of the first writhe in comparison
with control group (7.31.3 min) (Figure
7A). EOVAC at dose of 50 mg/kg
increased the latency time (12.282.5 min)
to the beginning of the first writhe but this
effect was not statistically significant
(Figure 7a).

AJP, Vol. 5, No. 3, May-Jun 2015

224

Effect of Vitex agnus-castus essential oil on pain

Table1. The major components (%) of Vitex agnuscastus leave essential oil.
N
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22

Figure 7. The effects of essential oil of Vitex agnuscastus and piroxicam on latency time to the
beginning of the first writhe (a) and writhe numbers
(b) in acetic acid-induced visceral pain in rat. *
p<0.05, p<0.01 as compared with control group
(n=5/group). (One way ANOVA followed by
Tukeys HSD post hoc test). EOVAC: Essential oil
of Vitex agnus-castus.

Acute toxicity
The essential oil of Vitex agnus-castus
leaves showed no animal mortality even at
dose of 5000 mg/kg in a period of 2 days.
The LD50 value of this essential oil in mice
is estimated to be more than 5 g/kg, (p.o.).
GC-MS analysis
The chemical composition of EOVAC
was analyzed using GC-MS, which
identified 22 compounds, representing
68.37% of total oil compounds.
According to these results, major
components of the EOVAC were -pinene
(14.83%),
limonene
(10.29%),
caryophyllene (6.9%), sabinene (5.27%),
and -farnesene (5.9%). The major
composition of EOVAC is represented in
Table 1.

Compound
- Pinene
Sabinene
- Myrcene
Phellandrene
-Terpinene
Limonene
-Terpinene
- Terpinolene
Linalool
- Terpinenyl acetat
- Bergamotene
Eugenol
- Caryophyllene
- Farnesene
- Curcumene
Germacrene-D
- Selinene
- Aminomethylene
glutaconic anhydride
- Sesquiphellandrene
Caryophyllene oxide
- Eudesmol
- Bisabolol

RT1
8.19
8.76
8.98
9.18
9.38
9.73
10.00
10.39
10.51
13.25
13.62
13.36
14.07
14.20
14.47
14.56
14.63
14.75
14.83
15.43
15.95
16.1

%
14.83
5.27
1.49
0.52
0.67
10.29
0.85
0.55
0.86
2.92
2.19
1.71
6.9
5.9
1.4
2.26
1.44
1.32
1.86
1.58
2.14
1.42

Discussion
In this study, three different nociceptive
tests (formalin test, acetic acid-induced
writhing response, and tail immersion test)
were employed for evaluation of possible
peripheral and central effects of the Vitex
agnus-castus essential oil. Using these
methods, it was revealed that subcutaneous
injection
of
EOVAC
produced
antinociceptive effects in the rats.
Subcutaneous injection of formalin
2.5% into the ventral surface of right hind
paw produced a biphasic pattern of
nociceptive responses in rats. Each phase
of formalin test has different mechanisms
of nociception. The first phase is produced
by direct simulative effect of formalin on
myelenated and unmyelenated nociceptive
afferent fibers, mainly C fibers which
corresponds
to
acute
nociceptive
neurogenic pain (Shields et al., 2010). This
phase of formalin pain is more sensitive to
opioidergic agents effect. The second
phase of formalin test is associated with
release of several inflammatory mediators
and excitatory amino acids such as
glutamate and aspartate (Omote et al.,
1998) causing an inflammatory type of

AJP, Vol. 5, No. 3, May-Jun 2015

225

Khalilzadeh et al.

nociception and is very sensitive to antiinflammatory actions of non-steroid antiinflammatory drugs as the cyclooxygenase
inhibitors (Couto et al., 2011). Several
studies suggested that the chemicals or
drugs that act as analgesic via activation of
central mechanisms of analgesia can
inhibit both phases of formalin test
whereas peripherally acting drugs can
inhibit only the late phase (Yamamoto and
Nozaki-Taguchi, 2002). Our results
showed that EOVAC significantly reduced
licking and biting behaviors in the both
phases of formalin test and increased
latency time in the tail immersion test at
various time points post-treatment in rats.
These findings suggested that the analgesic
activity of EOVAC is mediated by both
peripheral and central antinociceptive
mechanisms in these models of
nociception.
In the present study, intraperitoneal
injection of morphine (10 mg/kg)
produced an inhibitory effect on both
phases of formalin pain and also increased
latency time in the tail immersion test.
Moreover, pretreatment with naloxone (a
non-selective opioid receptors antagonist),
at a dose that did not produce any
significant effect on the formalin pain or
thermal pain responses, completely
prevented analgesia induced by EOVAC
on both phases of the formalin test as well
as tail immersion test. These results
indicated that at least part of the
antinociceptive effect observed from
EOVAC is due to activation of
endogenous opioidergic system.
Webster et al., (2011) reported that
different fractions of Vitex agnus-castus
extract act as an agonist of and but not
opioid receptors. In addition, four days
feeding of rats with VAC caused a
significant increase in brain and blood
levels of -endorphin (endogenous opioid
agonist) (Samochowiec et al., 1998).

Opioidergic activity exhibited by VAC

may be one of the important mechanisms
of action of VAC in reduction of pain and
treatment of PMS syndrome (Webster et
al., 2011).
In the present study, it was revealed that
pretreatment with atropine (1 mg/kg)
significantly prevented the analgesic effect
of EOVAC (50 mg/kg) in the formalin test
as well as tail immersion test. These results
suggest an acetylcholine muscarinic
receptors involvement in the analgesic
effect induced by EOVAC. Cholinergic
system has an important role in the pain
modulation (Jones and Dunlop, 2007).
EOVAC contains some of terpenes such as
(-)-Linalool and -phellandrene that
produce analgesia via activation of
cholinergic system (Peana et al., 2003;
Lima et al., 2012).
In the writhing test, our results showed
that the EOVAC and piroxicam (nonselective cyclooxygenase inhibitor) as a
positive control significantly reduced
writhing response. This model of visceral
nociception is a typical model of
inflammatory pain and also accepted as a
screening method for the assessment of
analgesic
and/or
anti-inflammatory
properties of new compounds and
chemicals (Tjlsen and Hole, 1997).
Acetic acid promotes the release of
prostaglandins, serotonin, and histamine in
the peritoneal fluids (Deraedt et al., 1980).
Therefore, the current results suggested
that the EOVAC significantly produced
inhibitory effect in this inflammatory
model of pain, and this effect may be
related to its suppressive effect on the
biosynthesis pathway of pro inflammatory
substances or reduction of endogenous
pro-inflammatory substances release.
Therapeutic effects of VAC in PMS
syndrome were already well documented
(Prilepskaya et al., 2006). In an openlabeled clinical observation on migrainous
women with PMS, the VAC (40 mg/day)

AJP, Vol. 5, No. 3, May-Jun 2015

226

Effect of Vitex agnus-castus essential oil on pain

was administrated for a 3-month period

and the results indicated that VAC could
improve preventative management of both
menstrual- and non-menstrual-related
migraine headaches.
Furthermore, it was safe and well tolerated
by patients (Ambrosini et al., 2012).
EOVAC showed a rapid analgesic
effect in the tail immersion test. The
analgesic effect of EOVAC was started
from 15 min after administration. This
result suggested that EOVAC had a rapid
analgesic effect. This rapid effect of
EOVAC may be due to its lipophilic
nature. Because of this lipophilic
character, the EOVAC allowed to rapidly
absorb from injection site and also rapidly
penetrated the blood brain barrier and
reached the central nervous system
(Buchbauer et al., 1993). Some of
constituents of essential oils such as
linalool, eugenol, menthol, and thymol can
act on the central and peripheral nervous
system as ion channel modulators (De
Arajo et al., 2011).
Previous report showed that major
essential oil components of the ripe fruits
of Vitex agnus castus varied in dependence
of grinding, maturity, distillation period,
and method of extraction used (Sorensen
and Katsiotis, 2000). A study on the
essential oil obtained from Vitex agnus
castus grown in Turkey resulted in the
detection of 27 components. This study
showed that major components of the oil
were 1,8-cineole (24.98%), sabinene
(13.45%), -pinene (10.60%), -terpinyl
acetate (6.66%), and (Z)--farnesene
(5.40%) (Sarikurkcu et al., 2009). These
data are different (in percentage and
composition) from our GC-MS findings.
We observed high concentration of pinene, R-(+)-limonene, -caryophyllene,
and sabinene in the EOVAC composition.
R-(+)-limonene and -pinene demonstrated
analgesic effects in different models of
pain (Guimares et al., 2013). In addition,
sabinene (1%) has been reported to act as
an anti-inflammatory agent in the

crystalline-induced ocular inflammation in

rabbit eyes (Sheng and Chiou, 1993). caryophyllene is another component which
exists in the EOVAC. This sesquiterpene
has a functional non-psychoactive CB2
cannabinoid receptor agonistic activity
(Gertsch et al., 2008). Cannabinoid
receptor CB2 and its selective agonist were
accepted as a new pharmacological target
for the treatment of pain (Anand et al.,
2009). Moreover, - caryophyllene has
been shown to inhibit inflammation in the
mouse model of experimental colitis
induced by dextran sulfate sodium (Cho et
al., 2006) and have a local anesthetic effect
(Ghelardini et al., 2001). Caryophyllene
oxide and eugenol are the other two active
ingredients that we found in our extracted
EOVAC. Chavan et al., (2010) described
that caryophyllene oxide has an analgesic
activity in both hot plate and acetic acidinduced writhing test in mice and also has
an
anti-inflammatory
action
in
carrageenan- induced paw edema in Wistar
rats.
Eugenol is a phenylpropene derivative,
well known as local anesthetic, analgesic
(Park et al., 2009), and anti-inflammatory
agent (Hashimoto et al., 1988) that is
widely used in dentistry.
Taken all together, we suggest that at
least a part of antinociceptive property of
EOVAC may depend on its caryophyllene, caryophyllene oxide, pinene, limonene, eugenol, and sabinene
content.
In the toxicity study, using gavage
technique for oral administration of
EOVAC at the doses of 1, 2, 3, and 5 g/kg
revealed that essential oil was not toxic in
mice and we didnt see any mortality.
According to these finding, the LD50
value of EOVAC in mice was estimated to
be more than 5 g/kg, p.o. which it can be
well tolerated by animals.
In conclusion, our results indicate that the
EOVAC produced analgesic effect in these
models of nociception and this effect
seems to be mediated by activation of

AJP, Vol. 5, No. 3, May-Jun 2015

227

Khalilzadeh et al.

endogenous opioidergic system and

muscarinergic receptors of cholinergic
system. In addition, part of antinociceptive
activity of Vitex agnus castus essential oil
may be due to its anti-inflammatory effect.
Conflict of Interest
The authors have declared that there is
no conflict of interest.

References
Abbott FV, Bonder M. 1997. Options for
management of acute pain in the rat. Vet
Rec, 140: 553-557.
Ambrosini A, Di Lorenzo C, Coppola G,
Pierelli F. 2013. Use of Vitex agnus-castus
in migrainous women with premenstrual
syndrome:
an
open-label
clinical
observation. Acta Neurol Belg, 113: 2529.
Anand P, Whiteside G, Fowler CJ, Hohmann
AG. 2009. Targeting CB2 receptors and
the endocannabinoid system for the
treatment of pain. Brain Res Rev, 60: 255266.
Atmaca M, Kumru S, Tezcan E. 2003.
Fluoxetine
versus Vitex
agnus
castus extract in the treatment of
premenstrual dysphoric disorder. Hum
Psychopharmacol, 18: 191-195.
Buchbauer G, Jirovetz L, Jager W, Plank C,
Dietrich H. 1993. Fragrance compounds
and essential oils with sedative effects
upon inhalation. J Pharm Sci, 82: 660-664.
Chavan MJ, Wakte PS, Shinde DB. 2010.
Analgesic and anti-inflammatory activity
of Caryophyllene oxide from Annona
squamosa L. bark. Phytomedicine, 17:
149-151.
Cho JY, Chang HJ, Lee SK, Kim HJ, Hwang
JK, Chun HS. 2006. Amelioration of
dextran sulfate sodium-induced colitis in
mice by oral administration of caryophyllene, a sesquiterpene. Life Sci,
80: 932-939.
Choudhary MI, Jalil AS, Nawaz SA, Khan
KM, Tareen RB, Attaur R. 2009. Antiinflammatory and lipoxygenase inhibitory
compounds from Vitex agnus-castus.
Phytoter Res, 23: 1336-1339.

Christaki E, Bonos E, Giannenas I, FlorouPaneri P. 2012. Aromatic plants as a

source
of
bioactive
compounds.
Agriculture, 2: 228- 243.
Couto VM, Vilela FC, Dias DF, dos Santos
MH, Soncini Roseli, Giovani OC
Nascimento, Alexandre Giusti-Paiva.
2011. Antinociceptive effect of extract of
Emilia
sonchifolia
in
mice.
J
Ethnopharmacol, 134: 348-353.
D'Antuono LF, Galletti GC, Bocchini P.
2000.Variability of Essential Oil Content
and Composition of Origanum vulgare L.
Populations from a North Mediterranean
Area (Liguria Region, Northern Italy).
Ann Bot, 86: 471-478.
De Arajo DAM, Christiane Freitas, Jader SC.
2011. Essential oils components as a new
path to understand ion channel molecular
pharmacology. Life Sci, 89: 540-544.
Deraedt R, Jouguey S, Delevalle F, Falhaut
M. 1980. Release of prostaglandins E and
F in an algogenic reaction and its
inhibition. Eur J Pharmacol, 61: 1724.
Dugoua JJ, Seely D, perri D, Koren G, Mills
E. 2008. Safety and efficacy of chaste tree
(Vitex agnus castus) during pregnancy and
lactation. Can J Pharmacol, 15: 74-79.
Ghannadi A, Bagherinejad MR, Abedi D,
Jalali M, Absalan B, Sadeghi N. 2012.
Antibacterial activity and composition of
essential
oils
from
Pelargonium
graveolens LHer and Vitex agnus-castus
L. Iran J Microbiol, 4: 171-176.
Gertsch J, Leonti M, Raduner S, Racz I, Chen
JZ, Xie XQ, Altmann KH, Karsak M,
Zimmer A. 2008. Beta-caryophyllene is a
dietary cannabinoid. Proc Natl Acad Sci
USA, 26: 9099-9104.
Ghelardini C, Galeotti N, Mannelli LDC,
Mazzanti G, Bartolini A. 2001. Local
anaesthetic activity of -caryophyllene.
Farmaco, 56: 387-389.
Guimares AG, Quintans JSS, Quintans-Jnior
LJ. 2013. Monoterpenes with analgesic
activity- a systematic review. Phytother
Res, 27: 1-15.
Jones PG, Dunlop J. 2007. Targeting the
cholinergic system as a therapeutic
strategy for the treatment of pain.
Neuropharmacology, 53:197-206.
Hashimoto S, Uchiyama K, Maeda M,
Ishitsuka K, Furumoto K, Nakamura Y.

AJP, Vol. 5, No. 3, May-Jun 2015

228

Effect of Vitex agnus-castus essential oil on pain

1988. In vivo and in vitro effects of zinc

oxide-eugenol (ZOE) on biosynthesis of
cyclo-oxygenase products in rat dental
pulp. J Dent Res, 67: 1092-1096.
Khalilzadeh E, Tamaddonfard E, Farshid AA,
Erfanparast A. 2010. Microinjection of
histamine into the dentate gyrus produces
antinociception in the formalin test in rats.
Pharmacol Biochem Behav, 97: 325332.
Le Bars D, Gozariu M, Cadden SW. 2001.
Animal models of nociception. Pharmacol
Rev, 53: 597-652.
Lima DF, Brando MS, Moura JB, Leito JM
R S, Carvalho FAA, Mira LMCV, Leite
JRSA, Sousa DP, Almeida FRC. 2012.
Antinociceptive
activity
of
the
monoterpene -phellandrene in rodents:
possible mechanisms of action. J Pharm
Pharmacol, 64: 283292.
Mahmoudi R, Zare P, Hassanzadeh P,
Nosratpour S. 2014. Effect of Teucrium
polium
essential
oil
on
the
physicochemical and sensory properties of
probiotic yoghurt. J Food Process Pres, 38:
880-888.
Nasri S, Ebrahimi S. 2006. Medical effect of
Vitex agnus- castus. Journal of Babol
University of medical Science, 7: 49-53.
Ness TJ. 1999. Models of visceral nociception.
Inst Lab Anim Res J, 40: 119-128.
Omote K, Kawamata T, Kawamata M, Namiki
A. 1998. Formalin-induced release of
excitatory amino acids in the skin of the rat
hind paw. Brain Res, 787: 161-164.
Park CK, Kim K, Jung SJ, Kim MJ, Ahn DK,
Hong SD, Kim JS, Oh SB. 2009. Molecular
mechanism for local anesthetic action of
eugenol in the rat trigeminal system. Pain,
144: 84-94.
Peana AT, D'Aquila PS, Chessa ML, Moretti
MD, Serra G, Pippia P. 2003. (-)-Linalool
produces
antinociception
in
two
experimental models of pain. Eur J
Pharmacol, 460: 37-41.
Prilepskaya VN, Ledina AV, Tagiyeva AV,
Revazova FS. 2006. Vitex agnus castus:
successful treatment of moderate to severe
premenstrual syndrome. Maturitas, 55:
S55S63.
Ramezani M, Amin GH, Jalili E. 2010.
Antinociceptive and Anti-inflammatory
Effects of Hydroalcohol Extract of Vitex

agnus castus Fruit. World Acad Sci Eng

Technol, 64: 619-621.
Samochowiec L, Glaesmer R, Samochowiec J.
1998. Einfluss von Monchspfeffer auf die
Konzentration von beta-Endorphine im
Serum
weiblicher
Ratten.
rztez
Naturheilverfahren, 39: 213-215.
Saberi M, Rezvanizadeh A, Bakhtiarian A.
2008. The antiepileptic activity of Vitex
agnus castus extract on amygdala kindled
seizures in male rats. Neurosci Lett, 441:
193-196.
Safa O, Soltanipoor MA, Rastegar S, Kazemi
M, Nourbakhsh Dehkordi K, Ghannadi A.
2012. An ethnobotanical survey on
hormozgan province, Iran. Avicenna J
Phytomed, 3: 64-81.
Sarikurkcu C, Arisoy K, Tepe B, Cakir A,
Abali G, Mete E. 2009. Studies on the
antioxidant activity of essential oil and
different
solvent
extracts
of
Vitexagnuscastus L. fruits from Turkey.
Food Chem Toxicol, 47: 2479-2483.
Sheng YQ, Chiou GCY. 1993. Inhibition of
crystallins induced inflammation in rabbit
eyes with five phytogenic compounds. Acta
Pharmacol Sin, 14: 13-17.
Shields SD, Cavanaugh DJ, Lee H, Anderson
DJ, Basbaum AI. 2010. Pain behavior in
the formalin test persists after ablation of
the great majority of C-fiber nociceptors.
Pain, 151: 422-429.
Sorensen JM, Katsiotis ST. 2000. Parameters
influencing the yield and composition of
the essential oil from Cretan V. agnuscastus fruits. Planta Med, 66: 245-250.
Stojkovic D, Sokovic M, Glamoclija J,
Dzamic A, Ciric A, Ristic M, Grubiic D.
2011.
Chemical
composition
and
antimicrobial activity of Vitex agnus-castus
L. fruits and leaves essential oils. Food
Chem, 128: 1017-1022.
Tamaddonfard E, Tajik H, Hamzeh-Gooshchi
N. 2008. Effects of curcumin and vitamin C
on visceral nociception induced by acetic
acid in rats. Med Weter, 64: 883-885.
Tjlsen A, Hole K. 1997. Animal models of
analgesia. In: Dickenson A, Besson JM,
The Pharmacology of Pain, PP: 1-20,
Berlin Heidelberg, Springer-Verlag.
Upton R. 2001. Chaste tree fruit, Vitex agnuscastus. In: Santa Cruz CA, standards of
analysis, quality control, and therapeutics,

AJP, Vol. 5, No. 3, May-Jun 2015

229

Khalilzadeh et al.
pp.
13-31,
American
Herbal
Pharmacopoeia.
Webster DE, He Y, Chen SN, Pauli GF,
Farnsworth
NR,
Wang ZJ. 2011.
Opioidergic mechanisms underlying the
actions of Vitex agnus-castus L. Biochem
Pharmacol, 81: 170-177.

Yamamoto T, Nozaki-Taguchi N. 2002. The

role of cyclooxygenase-1 and -2 in the rat
formalin test. Anesth Analg, 94: 962-967.
Zimmermann M. 1983. Ethical guidelines for
investigations of experimental pain in
conscious animals. Pain, 16: 109-110.

AJP, Vol. 5, No. 3, May-Jun 2015

230